|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96,300 KRW | +1.58% |
|
+2.77% | -9.32% |
| May. 02 | OCI Q1 Profit Down 18% Despite 20% Sales Growth | MT |
| Apr. 25 | OCI Holdings Signs MoU to Accelerate Solar Business | MT |
OCI Company Ltd. (KOSE:A010060) agreed to acquire an additional 10.878134% stake in Bukwang Pharmaceutical Co., Ltd. (KOSE : A003000) from Kim Sanghun and 8 other shareholders for approximately KRW 150 billion on February 22, 2022. The consideration will be paid in cash. Upon completion, OCI Company will hold 10.90% stake in Bukwang Pharmaceutical.
The transaction is expected to close on March 8, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.32% | 1.39B | |
| +2.56% | 102B | |
| -1.92% | 66.01B | |
| +47.62% | 41.76B | |
| +15.99% | 38.66B | |
| +4.25% | 32.28B | |
| +8.78% | 19.57B | |
| +12.32% | 16.77B | |
| +17.69% | 15.08B | |
| +8.31% | 14.83B |
OCI HOLDINGS COMPANY LTD. 
